Norwegian Cancer Society
In research, Norwegian Cancer Society stands highest in Medicine (#1,993 of 17,978 worldwide), Life Sciences (#1,642 of 14,347 worldwide) and Health Sciences (#2,695 of 20,462 worldwide), over all time.
- World rank, 2022–2025
- #16,262 of 28,054 · #4,034 all time
- Rank in Norway
- #80 of 133
- Research works
- 3.8k ▼ 41% vs 2013–17
- Citations
- 185k 48.9 per fractional work
- Top-10% rate
- 21.4% record average 16.5%
- Open access
- 28% world 28%
What is Norwegian Cancer Society known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #1,993 of 17,978 | 23.3% | 1,987 | |
| Life SciencesDomain | #1,642 of 14,347 | 23.8% | 1,432 | |
| Health SciencesDomain | #2,695 of 20,462 | 23.3% | 2,032 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,399 of 7,814 | 24.0% | 1,152 | |
| Molecular BiologySubfield | #1,195 of 4,961 | 22.6% | 638 | |
| Pulmonary and Respiratory MedicineSubfield | #715 of 2,717 | 27.0% | 282 | |
| SurgerySubfield | #1,331 of 4,227 | 26.5% | 247 | |
| OncologySubfield | #652 of 1,852 | 22.5% | 328 | |
| Physical SciencesDomain | #7,938 of 21,541 | 26.6% | 287 | |
| Immunology and MicrobiologyField | #1,076 of 1,980 | 22.0% | 198 |
Each strip is that field’s whole ranked pool, with the notch where Norwegian Cancer Society sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.2×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 5.2×
- Immunology and Microbiology 4.2×
- Medicine 3.2×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Neuroscience 0.5×
- Economics, Econometrics and Finance 0.3×
- Dentistry 0.3×
- Physics and Astronomy 0.2×
- Chemistry 0.2×
- Engineering 0.2×
- Materials Science 0.2×
- Psychology 0.2×
- Decision Sciences 0.1×
- Health Professions 0.1×
- Computer Science 0.1×
- Environmental Science 0.0×
- Mathematics 0.0×
- Agricultural and Biological Sciences 0.0×
- Social Sciences 0.0×
Who are the top researchers at Norwegian Cancer Society?
Ranked on the composite score, Johan Moan, Gunnar B. Kristensen and Per O. Seglen lead among researchers whose main affiliation is Norwegian Cancer Society.
- 1 Johan Moan Norway · #9,745 worldwide 860 citations · 64 works
- 2 Gunnar B. Kristensen Norway · #14,142 worldwide 396 citations · 53 works
- 3 Per O. Seglen Norway · #22,505 worldwide 634 citations · 47 works
- 4 Kristian Berg Norway · #23,438 worldwide 732 citations · 40 works
- 5 Alexander Pihl Norway · #31,679 worldwide 333 citations · 45 works
- 6 Sophie D. Fosså Norway · #47,569 worldwide 496 citations · 136 works
- 7 Sjur Olsnes Norway · #53,075 worldwide 431 citations · 46 works
- 8 Pål Møller Norway · #55,755 worldwide 315 citations · 55 works
- 9 Per Kolstad Norway · #68,999 worldwide 206 citations · 29 works
- 10 Vera M. Abeler Norway · #70,126 worldwide 203 citations · 30 works
Which keywords describe research at Norwegian Cancer Society?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Clinical Practice Guidelines, Survival Analysis, Prognostic Factors, Cancer, Biomarkers and Cytoreductive Surgery.
- Soft Tissue Sarcoma
- Neoadjuvant Therapy
- Cell Death
- Cancer Immunotherapy
- Mutation Analysis
- Gene Expression
- Mutational Signatures
- Genomic Analysis
- Cancer Genomics
- Intraperitoneal Chemotherapy
- Endometrial Carcinoma
- Brachytherapy
- Genomic Instability
- Cervical Cancer
- Radiation Therapy
- Inflammation
- Clinical Trials
- Prognostic Factors
- Clinical Practice Guidelines
- Cancer
- Chemotherapy
- Immunotherapy
- Survival Analysis
- Biomarkers
- Cytoreductive Surgery
- Metastasis
- Targeted Therapy
- Tumor Microenvironment
- Molecular Classification
- Colorectal Cancer
- Ovarian Cancer
- Peritoneal Metastases
- Genetic Mutations
- Immunity
- Prostate Cancer
- Reactive Oxygen Species
- Tumor Models
- Gene Therapy
- Genomic Profiling
- Osteosarcoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy6▲ 14×16 topics
- Cancer5▲ 5.7×26 topics
- Immunotherapy5▲ 11×13 topics
- Clinical Practice Guidelines5▲ 14×8 topics
- Survival Analysis5▲ 27×4 topics
- Prognostic Factors4▲ 16×8 topics
- Biomarkers4▲ 9.2×8 topics
- Clinical Trials4▲ 8.9×7 topics
- Cytoreductive Surgery4▲ 92×2 topics
- Inflammation4▲ 2.7×22 topics
- Metastasis4▲ 16×7 topics
- Radiation Therapy4▲ 42×4 topics
- Targeted Therapy3▲ 22×4 topics
- Cervical Cancer3▲ 43×2 topics
- Tumor Microenvironment3▲ 10×7 topics
- Genomic Instability2▲ 35×3 topics
- Molecular Classification2▲ 24×2 topics
- Brachytherapy2▲ 89×1 topic
- Colorectal Cancer2▲ 45×2 topics
- Endometrial Carcinoma2▲ 89×1 topic
- Ovarian Cancer2▲ 39×3 topics
- Intraperitoneal Chemotherapy2▲ 165×1 topic
- Peritoneal Metastases2▲ 165×1 topic
- Cancer Genomics2▲ 44×1 topic
- Genetic Mutations2▲ 7.1×7 topics
- Genomic Analysis2▲ 13×2 topics
- Immunity2▲ 7.9×6 topics
- Mutational Signatures2▲ 44×1 topic
- Prostate Cancer2▲ 25×4 topics
- Gene Expression2▲ 4.9×8 topics
- Reactive Oxygen Species2▲ 7.5×7 topics
- Mutation Analysis2▲ 37×1 topic
- Tumor Models2▲ 47×1 topic
- Cancer Immunotherapy2▲ 18×3 topics
- Gene Therapy2▲ 14×4 topics
- Cell Death2▲ 11×5 topics
- Genomic Profiling2▲ 24×2 topics
- Neoadjuvant Therapy2▲ 11×5 topics
- Osteosarcoma2▲ 51×1 topic
- Soft Tissue Sarcoma2▲ 45×1 topic
Which research topics does Norwegian Cancer Society publish most on?
By volume in 2022–2025: Endometrial and Cervical Cancer Treatments, Intraperitoneal and Appendiceal Malignancies, Cancer Genomics and Diagnostics and Ovarian cancer diagnosis and treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 2 works
- 2 Intraperitoneal and Appendiceal Malignancies Surgery 2 works
- 3 Cancer Genomics and Diagnostics Cancer Research 2 works
- 4 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
- 5 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 6 Epigenetics and DNA Methylation Molecular Biology 1 works
- 7 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 8 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 9 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 10 Genetic factors in colorectal cancer Pathology and Forensic Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Norwegian Cancer Society's research output changed?
Output in 2018–2022 was 41% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Oslo
- University of Oslo
- Oslo University Hospital
- OsloMet – Oslo Metropolitan University
- Norwegian Institute of Public Health
- BI Norwegian Business School
- Norwegian Defence Research Establishment
- Norsk Hydro (Norway)
- The Research Council of Norway
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.